Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...
Dr. Monty Pal introduces the program by outlining the evolving treatment landscape for advanced renal cell carcinoma (RCC) ...
King Faisal Specialist Hospital and Research Centre in Jeddah has successfully developed and implemented the world’s first protocol of ...
New factor XIa inhibitors cut recurrent non-cardioembolic stroke without extra bleeding—plus what milvexian and abilacimab trials reveal. In this installment of this series, ‘The Future of Factor XIa ...
LIVN's PolySync data show an 84.5% AHI response rate in OSA patients, building on OSPREY results for its aura6000 System.
King Faisal Specialist Hospital and Research Centre in Jeddah has successfully developed and implemented the world's first protocol of ...
Key Points Immuron Engages Pullan Consulting to Advance IMM-529 Partnering Strategy Immuron is seeking a partner to support ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the primary efficacy endpoint at Week 48 was met in both the ...
20h
Read-only wearable devices vs. read-write systems: How insulin pumps and more rewrite body signals
Now a new generation of devices is trying to do something the read-only wearable never could, talk back to the body.
14h
Oaks Law Firm Explains How Artificial Intelligence Is Reshaping California Personal Injury Claims
SHERMAN OAKS, CA, UNITED STATES, July 6, 2026 /EINPresswire.com/ -- Los Angeles, California Artificial intelligence has ...
For decades, treating depression has largely involved a difficult form of medical guesswork: prescribing one antidepressant ...
The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results